Table 2.
Baseline | Cocaine | |
---|---|---|
Myocardial contrast echocardiography | ||
Myocardial A, a.u | 134 ± 5 | 112 ± 8* |
Myocardial β, s-1 | 0.8 ± 0.1 | 0.7 ± 0.1 |
Myocardial perfusion (A·β), a.u.·s-1 | 104 ± 10 | 76 ± 11* |
Myocardial conductance, a.u.·mmHg-1 | 1.5 ± 0.2 | 0.9 ± 0.2* |
Hemodynamics | ||
Heart rate, beats·min-1 | 65 ± 2 | 73 ± 3* |
Systolic Blood Pressure, mmHg | 111 ± 3 | 125 ± 4* |
Diastolic Blood Pressure, mmHg | 53 ± 2 | 67 ± 2* |
Mean Blood Pressure, mmHg | 72 ± 2 | 86 ± 3* |
LV End-diastolic volume, mL | 152 ± 7 | 158.3 ± 7.4 |
LV End-systolic volume, mL | 56 ± 4 | 53 ± 3 |
LV Stroke volume, mL | 96 ± 5 | 105 ± 7* |
Indices of LV work, function and oxygen demand | ||
LV Ejection Fraction, % | 64 ± 1 | 66 ± 2 |
LV end-systolic elastance, mmHg·mL-1 | 1.9 ± 0.2 | 2.5 ± 0.3* |
LV end-systolic wall stress, 103 dyn/cm2 | 0.7 ± 0.1 | 0.8 ± 0.1 |
LV stroke work (×10-3), mmHg·mL-1 | 9.6 ± 0.4 | 11.9 ± 0.8* |
LV total work, mmHg·mL-1·bpm-1 | 125.6 ± 14.3 | 176.9 ± 17.2* |
MVO2, ml·min-1 | 6.7 ± 0.3 | 8.1 ± 0.4* |
Data reported as mean ± SEM.
P < 0.05.
RBC, red blood cell; LV, left ventricle; MVO2, myocardial oxygen consumption